Results 21 to 30 of about 7,978,447 (307)

Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD [PDF]

Clinical Journal of the American Society of Nephrology, 2016
Soluble TNF-like weak inducer of apoptosis (sTWEAK) is a proinflammatory cytokine belonging to the TNF superfamily. sTWEAK concentrations have been associated with the presence of CKD and cardiovascular disease (CVD). We hypothesized that sTWEAK levels may relate to a higher prevalence of atherosclerotic plaques, vascular calcification, and ...
Fernández-Laso, V., Sastre, Cristina, Valdivielso Revilla, José Manuel, Betriu i Bars, M. Àngels, Fernández i Giráldez, Elvira, Egido, Jesús, Martín-Ventura, JL., Blanco-Colio, LM.   +7 more
openaire   +3 more sources

Impact of Low Baseline Low‐Density Lipoprotein Cholesterol on Long‐Term Postdischarge Cardiovascular Outcomes in Patients With Acute Myocardial Infarction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Real‐world data on low baseline low‐density lipoprotein cholesterol (LDL‐C) levels and long‐term postdischarge cardiovascular outcomes in patients with acute coronary syndrome are limited. Methods and Results Of the 10 719 patients enrolled in
Kyung Hoon Cho, Min Chul Kim, Eun Ho Choo, Ik Jun Choi, Su Nam Lee, Mahn‐Won Park, Chul Soo Park, Hee‐Yeol Kim, Chan Joon Kim, Doo Sun Sim, Ju Han Kim, Young Joon Hong, Myung Ho Jeong, Kiyuk Chang, Youngkeun Ahn   +14 more
doaj   +1 more source

Prognostic value of high-sensitivity cardiac troponin for major adverse cardiovascular events in patients with diabetes: a systematic review and meta-analysis [PDF]

PeerJ, 2023
Background High-sensitivity cardiac troponin (hs-cTn) is associated with cardiovascular outcomes in the general population, but the prognostic value of hs-cTn in the diabetic population remains inconclusive.
Tiange Song, Yu Lan, Kecheng Li, Honglang Huang, Li Jiang   +4 more
doaj   +2 more sources

Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: a retrospective cohort study. [PDF]

, 2023
Background While the cardiovascular risks of androgen receptor pathway inhibitors have been studied, they were seldom compared directly. This study compares the risks of major adverse cardiovascular events (MACE) between enzalutamide and abiraterone ...
Jeremy Man Ho Hui, Chi Fai Ng, Chi Ho Leung, Yan Hiu Athena Lee, Christopher Tze Wei Tsang, Paul L. Nguyen, Gary Tse, Kyle Hui, Sean McBride, Pias Tang, Kenrick Ng, Jeffrey Shi Kai Chan, Edward Christopher Dee   +12 more
core   +3 more sources

Predictors for major adverse cardiovascular events.

, 2021
Predictors for major adverse cardiovascular events.
Joo-Hee Zo (721373), Jae-Bin Seo (721370), Myung-A Kim (721372), Woo-Hyun Lim (6157328), Hack-Lyoung Kim (654343), Sang-Hyun Kim (282188), Inki Moon (8293041)   +6 more
core   +1 more source

Machine Learning Based Risk Prediction for Major Adverse Cardiovascular Events [PDF]

, 2021
Background: Patients with major adverse cardiovascular events (MACE) such as myocardial infarction or stroke suffer from frequent hospitalizations and have high mortality rates. By identifying patients at risk at an early stage, MACE can be prevented with the right interventions.
Michael Schrempf, Diether Kramer, Stefanie Jauk, Sai Pavan Kumar Veeranki, Werner Leodolter, Peter P. Rainer   +5 more
openaire   +3 more sources

2015 Update on Acute Adverse Reactions to Gadolinium based Contrast Agents in Cardiovascular MR. Large Multi-National and Multi-Ethnical Population Experience With 37788 Patients From the EuroCMR Registry [PDF]

, 2015
Objectives: Specifically we aim to demonstrate that the results of our earlier safety data hold true in this much larger multi-national and multi-ethnical population.
Pilz, G., Nothnagel, D., Schneider, S., Sechtem, U, Sechtem, U., Pilz, G, van Rossum, AC, Nagel, E, Greulich, S., Rossum, A.C., Buss, Sebastian, Schwitter, J., Lombardi, M., Greulich, S, Lombardi, M, Wagner, A, Wagner, A., Bruder, O, Buss, S, Mahrholdt, H, Nothnagel, D, Bruder, O., Schwitter, J, Petersen, S., Jensen, C., Jensen, C, Buss, S., Mahrholdt, H., Nagel, E., Schneider, S, van Rossum, A.C., Petersen, S, Buss S, Sechtem U, Nagel E, Jensen C, van Rossum AC, Schwitter J, Wagner A, Lombardi M, Schneider S, Bruder O, Pilz G, Greulich S, Nothnagel D, Mahrholdt H, Petersen S   +46 more
core   +1 more source

Objective Sleep Efficiency Predicts Cardiovascular Disease in a Community Population: The Sleep Heart Health Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background There was little evidence about the role of objective sleep efficiency (SE) in the incidence of major cardiovascular disease (CVD) events.
Bin Yan, Jian Yang, Binbin Zhao, Yajuan Fan, Wei Wang, Xiancang Ma   +5 more
doaj   +1 more source

Validating the SMART2 Score in a Racially Diverse High‐Risk Nationwide Cohort of Patients Receiving Coronary Artery Bypass Grafting

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background We tested the potential of the Secondary Manifestations of Arterial Disease (SMART2) risk score for use in patients undergoing coronary artery bypass grafting.
Salil V. Deo, Andrew Althouse, Sadeer Al‐Kindi, David A. McAllister, Ariela Orkaby, Yakov E. Elgudin, Stephen Fremes, Danny Chu, Frank L. J. Visseren, Jill P. Pell, Naveed Sattar   +10 more
doaj   +1 more source

Baseline characteristics according to major adverse cardiovascular events.

, 2021
Baseline characteristics according to major adverse cardiovascular events.
Joo-Hee Zo (721373), Jae-Bin Seo (721370), Myung-A Kim (721372), Woo-Hyun Lim (6157328), Hack-Lyoung Kim (654343), Sang-Hyun Kim (282188), Inki Moon (8293041)   +6 more
core   +1 more source